Ahmed Ansari, MD
Dermatology · Rochester, MNNPI 1245791433
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,086, more than ten times the $35 reported in 2023.
Across 62 payments — averaging $20.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$218
- LEO Pharma Inc.$206
- AbbVie$195
- Incyte Corporation$105
- Sun Pharmaceutical Industries Inc.$96
- Journey Medical Corporation$62
- plus $409 from 14 others
What the payments were for
- Food & beverage$1,291100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $218 |
| LEO Pharma Inc. | 11 | $206 |
| AbbVie | 10 | $195 |
| Incyte Corporation | 5 | $105 |
| Sun Pharmaceutical Industries Inc. | 6 | $96 |
| Journey Medical Corporation | 2 | $62 |
| Johnson & Johnson | 3 | $56 |
| UCB, Inc. | 2 | $46 |
| Galderma Laboratories, L.p. | 2 | $37 |
| Boehringer Ingelheim | 1 | $37 |
| Organogenesis Inc. | 1 | $33 |
| Dermavant Sciences, Inc. | 2 | $32 |
| Amgen | 2 | $32 |
| Organon | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| Almirall LLC | 1 | $20 |
| Novartis | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $15 |
How this compares
$1,291 in reported general payments places this provider in the 80th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 129 | $5,041 |
| Tacrolimus | 20 | $2,472 |
| Fluocinonide | 39 | $2,346 |
| Fluorouracil | 32 | $2,329 |
| Ketoconazole | 104 | $1,945 |
| Triamcinolone Acetonide | 76 | $1,492 |
| Tretinoin | 12 | $1,070 |
| Doxycycline Hyclate | 42 | $1,040 |
| Clindamycin Phosphate | 20 | $847 |
| Metronidazole | 16 | $792 |
| Hydrocortisone | 52 | $451 |
| Mupirocin | 20 | $213 |
| Spironolactone | 14 | $213 |
| Prednisone | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rochester
- Afsaneh AlaviRochester$71K
- Saranya WylesRochester$25K
- Nessa Aghazadeh MohandesiRochester$11K
- Alina BridgesRochester$11K
- Megha TollefsonRochester$8K
- Julia LehmanRochester$8K
- Michael WangRochester$7K
- Michael CamilleriRochester$5K
- Jennifer MartinRochester$3K
- Julio Sartori-ValinottiRochester$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.